Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21617 | 354 | 37.4 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1581 | 6646 | COCAINE//NEONATAL ABSTINENCE SYNDROME//PRENATAL COCAINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MAIDS | Author keyword | 21 | 46% | 9% | 33 |
2 | LP BM5 | Author keyword | 11 | 69% | 3% | 9 |
3 | LP BM5 MURINE LEUKEMIA VIRUS | Author keyword | 9 | 83% | 1% | 5 |
4 | MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME | Author keyword | 9 | 67% | 2% | 8 |
5 | MURINE RETROVIRUS INDUCED IMMUNODEFICIENCY | Author keyword | 8 | 100% | 1% | 5 |
6 | MURINE AIDS | Author keyword | 7 | 29% | 6% | 21 |
7 | LP BM5 VIRUS | Author keyword | 6 | 80% | 1% | 4 |
8 | LP BM5 MULV | Author keyword | 4 | 50% | 2% | 6 |
9 | LP BM5 RETROVIRUS | Author keyword | 4 | 75% | 1% | 3 |
10 | RECOMBINANT T CELL RECEPTORS | Author keyword | 4 | 75% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MAIDS | 21 | 46% | 9% | 33 | Search MAIDS | Search MAIDS |
2 | LP BM5 | 11 | 69% | 3% | 9 | Search LP+BM5 | Search LP+BM5 |
3 | LP BM5 MURINE LEUKEMIA VIRUS | 9 | 83% | 1% | 5 | Search LP+BM5+MURINE+LEUKEMIA+VIRUS | Search LP+BM5+MURINE+LEUKEMIA+VIRUS |
4 | MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME | 9 | 67% | 2% | 8 | Search MURINE+ACQUIRED+IMMUNODEFICIENCY+SYNDROME | Search MURINE+ACQUIRED+IMMUNODEFICIENCY+SYNDROME |
5 | MURINE RETROVIRUS INDUCED IMMUNODEFICIENCY | 8 | 100% | 1% | 5 | Search MURINE+RETROVIRUS+INDUCED+IMMUNODEFICIENCY | Search MURINE+RETROVIRUS+INDUCED+IMMUNODEFICIENCY |
6 | MURINE AIDS | 7 | 29% | 6% | 21 | Search MURINE+AIDS | Search MURINE+AIDS |
7 | LP BM5 VIRUS | 6 | 80% | 1% | 4 | Search LP+BM5+VIRUS | Search LP+BM5+VIRUS |
8 | LP BM5 MULV | 4 | 50% | 2% | 6 | Search LP+BM5+MULV | Search LP+BM5+MULV |
9 | LP BM5 RETROVIRUS | 4 | 75% | 1% | 3 | Search LP+BM5+RETROVIRUS | Search LP+BM5+RETROVIRUS |
10 | RECOMBINANT T CELL RECEPTORS | 4 | 75% | 1% | 3 | Search RECOMBINANT+T+CELL+RECEPTORS | Search RECOMBINANT+T+CELL+RECEPTORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RETROVIRUS INDUCED IMMUNODEFICIENCY | 109 | 61% | 32% | 115 |
2 | SYNDROME MAIDS | 73 | 82% | 12% | 42 |
3 | MAIDS | 72 | 69% | 17% | 61 |
4 | DEFECTIVE VIRUS | 54 | 76% | 11% | 38 |
5 | SYNTHETIC AUTOANTIGENS | 29 | 88% | 4% | 14 |
6 | INDUCED IMMUNODEFICIENCY SYNDROME | 25 | 48% | 11% | 38 |
7 | LACKING THY 1 | 11 | 78% | 2% | 7 |
8 | B CELL LINEAGE | 8 | 52% | 3% | 11 |
9 | MURINE AIDS | 7 | 35% | 5% | 17 |
10 | JOINING SEGMENT PEPTIDE | 5 | 60% | 2% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ROLE OF T-CELL DERIVED CYTOKINES IN THE DOWN-REGULATION OF IMMUNE-RESPONSES IN PARASITIC AND RETROVIRAL INFECTION | 1992 | 398 | 57 | 14% |
Natural autoantibodies to TCR public idiotopes: Potential roles in immunomodulation | 2003 | 14 | 83 | 27% |
MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (MAIDS) - AN ANIMAL-MODEL TO STUDY THE AIDS PATHOGENESIS | 1991 | 177 | 62 | 35% |
Small animal models for acquired immune deficiency syndrome (AIDS) research | 1996 | 6 | 91 | 36% |
Animal models used for the evaluation of antiretroviral therapies | 2006 | 20 | 131 | 14% |
Structural, antigenic and evolutionary analyses of immunoglobulins and T cell receptors | 2002 | 5 | 64 | 30% |
Murine AIDS, a key to understanding retrovirus-induced immunodeficiency | 1996 | 14 | 85 | 22% |
Co-infection of Toxoplasma gondii with other pathogens: Pathogenicity and chemotherapy in animal models | 1996 | 2 | 29 | 28% |
Immune control of coxsackievirus-induced cardiopathology | 2003 | 0 | 67 | 24% |
SYNTHETIC AUTOANTIGENS OF IMMUNOGLOBULINS AND T-CELL RECEPTORS - THEIR RECOGNITION IN AGING, INFECTION, AND AUTOIMMUNITY | 1994 | 9 | 71 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOLEC BIOL 110 PINE AVE W | 1 | 100% | 0.6% | 2 |
2 | MASONIC CANC COMPARAT PATHOL SHARED OURCE | 1 | 40% | 0.6% | 2 |
3 | ALBERT B CHANDLER MED MED | 1 | 50% | 0.3% | 1 |
4 | BEN GURION CANC | 1 | 50% | 0.3% | 1 |
5 | FAMILY COMMUNITY MED 1501 N CAMPBELL AVE | 1 | 50% | 0.3% | 1 |
6 | KEY MOL JIANGXI PROV | 1 | 50% | 0.3% | 1 |
7 | MED MED IMMUNOL BIOL | 1 | 50% | 0.3% | 1 |
8 | ARIZONA ARTHRIT | 1 | 11% | 1.4% | 5 |
9 | GIFU | 0 | 20% | 0.6% | 2 |
10 | MINNC T PROGRAM | 0 | 20% | 0.6% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000208844 | RETROVIROL EPIGENET//POLYANTIGENIC IMMUNOMODULATOR//V HA RAS ONCOGENE |
2 | 0.0000116162 | PERSISTENT VIRAL DIS//FRIEND VIRUS//MOMULV TS1 |
3 | 0.0000093746 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |
4 | 0.0000079757 | PRO GSH MOLECULES//HIV 1 RELATED MORTALITY//HIV INFECTED ADULTS |
5 | 0.0000059710 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |
6 | 0.0000058578 | CARRIER ERYTHROCYTES//NANOERYTHROSOMES//HYPOTONIC DIALYSIS |
7 | 0.0000047719 | MOUSE MAMMARY TUMOR VIRUS//VIRAL SUPERANTIGEN//MAMMARY TUMOR VIRUS |
8 | 0.0000046855 | HYDROXYUREA//GENET HUMAN THER Y//TARGET CELL AVAILABILITY |
9 | 0.0000046577 | ELECTRON ION INTERACTION POTENTIAL//INFORMATIONAL SPECTRUM METHOD//DECEPTIVE IMPRINTING |
10 | 0.0000046561 | CANCER BIOTHERAPY//IST TIPIZZAZ TISSUTALE PROBLEMI DIALISI//INTRACELLULAR IMMUNOFLUORESCENCE |